Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1.
Saved in:
| Title: | Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1. |
|---|---|
| Authors: | Griffiths, Christopher E. M.1 (AUTHOR), Papp, Kim A.2 (AUTHOR), Song, Michael3 (AUTHOR), Miller, Megan3 (AUTHOR), You, Yin3 (AUTHOR), Shen, Yaung-Kaung3 (AUTHOR), Han, Chenglong3 (AUTHOR), Blauvelt, Andrew4 (AUTHOR) |
| Source: | Journal of Dermatological Treatment. Mar2022, Vol. 33 Issue 2, p848-856. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09546634 |
|---|---|
| DOI: | 10.1080/09546634.2020.1782817 |
